Convalescent plasma therapy for Covid 19 - A perspective

  • Mahmood A
  • Mahmood R
  • Khan M
  • et al.
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Convalescent plasma therapy has been used for years. However, its use in Covid-19 is still experimental. While it can be life-saving, its efficacy as well as risks need to be evaluated to establish this as a therapeutic option. Also, for this proper infrastructure and adequate facilities need to be in place before embarking on this journey. However, under current circumstances, convalescent plasma should be strictly only given in the setting of clinical trials.

Cite

CITATION STYLE

APA

Mahmood, A., Mahmood, R., Khan, M., Ali, S., Khan, N., & Jaffar, S. R. (2021). Convalescent plasma therapy for Covid 19 - A perspective. Hematology & Transfusion International Journal, 9(2), 28–30. https://doi.org/10.15406/htij.2021.09.00247

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free